194163-92-3 Usage
Description
(2S,4R)-1-tert-butyl 2-Methyl 4-(aMinoMethyl)pyrrolidine-1,2-dicarboxylate is a pyrrolidine derivative featuring a molecular structure with a pyrrolidine ring and two carboxylate groups. It is characterized by its specific stereochemistry and the presence of tert-butyl and aMinoMethyl substituents, which contribute to its potential pharmacological properties and interactions with biological systems.
Uses
Used in Medicinal Chemistry:
(2S,4R)-1-tert-butyl 2-Methyl 4-(aMinoMethyl)pyrrolidine-1,2-dicarboxylate is used as a compound in medicinal chemistry for its potential pharmacological properties, making it a candidate for drug development research.
Used in Drug Development Research:
In drug development research, (2S,4R)-1-tert-butyl 2-Methyl 4-(aMinoMethyl)pyrrolidine-1,2-dicarboxylate is utilized for its ability to interact with biological systems, which is crucial for the discovery and design of new therapeutic agents.
Used in Synthetic Organic Chemistry:
(2S,4R)-1-tert-butyl 2-Methyl 4-(aMinoMethyl)pyrrolidine-1,2-dicarboxylate is used as a valuable target in synthetic organic chemistry due to its unique stereochemistry and substitution pattern, which presents challenges and opportunities for the synthesis of novel compounds.
Used in Chemical Biology Studies:
In chemical biology, (2S,4R)-1-tert-butyl 2-Methyl 4-(aMinoMethyl)pyrrolidine-1,2-dicarboxylate is employed to study its interactions with biological systems, providing insights into its potential applications and mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 194163-92-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,1,6 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 194163-92:
(8*1)+(7*9)+(6*4)+(5*1)+(4*6)+(3*3)+(2*9)+(1*2)=153
153 % 10 = 3
So 194163-92-3 is a valid CAS Registry Number.
194163-92-3Relevant articles and documents
Efflux pump inhibitors
-
, (2008/06/13)
Compounds are described which have efflux pump inhibitor activity. Also described are methods of using such efflux pump inhibitor compounds and pharmaceutical compositions which include such compounds.
